Abbonarsi

Clinicopathological, dermoscopic features and circumstances of diagnosis of amelanotic or hypomelanotic melanoma: A prospective multicentric study in the French private medical sector - 06/04/24

Doi : 10.1016/j.annder.2024.103249 
E. Lorier Roy a, , J.-Y. Gourhant b, C. Derancourt c, N. Jouan d, A. Dupuy e, J.-F. Séi f

on behalf of the Fédération Française de Formation Continue en Dermato-Vénéréologieg

a Dermatologist, Private Practice, Paris, France 
b Dermatologist, Private Practice, Nemours, France 
c Dermatologist, Private Practice, Tallard, France 
d Dermatologist, Private Practice, Brest, France 
e Université Rennes, Centre Hospitalo-Universitaire de Rennes, Rennes, France 
f Dermatologist, Private Practice, Saint-Germain-en-Laye, France 
g Maison de la Dermatologie, Paris, France 

Corresponding author.

Abstract

Background

Amelanotic or hypomelanotic melanomas (AHM) are difficult to diagnose, and are often diagnosed late, with a high Breslow index and a poor prognosis.

Patients and methods

A total of 226 volunteer dermatologists consulting in private practice in France completed an online form for each new histologically proven case of melanoma diagnosed at their clinic in 2020. This anonymised survey collected data on the clinical, dermoscopic, and histological features of melanoma, as well as the circumstances of diagnosis and initial management. A group of 145 AHM was single out and compared to the 1503 pigmented melanomas (PM) from the same cohort.

Results

1503 pigmented melanomas (PM) and 145 AHM (8.8% of these melanomas) were identified and included. In the AHM group, the mean age at diagnosis was 65 ± 16 years, with no significant difference from the PM control group. AHM were not predominantly on the face and neck area, and there were no differences based on gender. Warning signs (local progression and bleeding) were significantly more frequent in the AHM group than in the PM group. AHM were more frequently ulcerated and nodular, with a higher median Breslow thickness than in the PM group (1.56 vs. 0.5 mm), and mitoses were more frequent. Dermoscopy was widely used and proved useful for distinguishing benign lesions, and for highlighting the vascular polymorphous pattern of malignant lesions. Patients noticed the suspicious lesion themselves in most cases of AHM (73.2%), as opposed to their general practitioner (17.2%) or entourage (9.5%). A total body skin examination enabled detection of 19.3% of AHM and 21.3% of PM where the patient consulted for another lesion, or for an unrelated reason.

Conclusion

AHM are difficult to diagnose for the clinician because of the paucity or absence of pigmentary criteria. Knowledge of dermoscopic vascular patterns is critical and could help reduce the median Breslow index of AHM at the time of detection. Self-examination of the skin should be encouraged, and simple algorithms for earlier detection of skin cancers should be promoted among health professionals and the general population.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Melanoma, Amelanotic, Hypomelanotic, Dermoscopy, Private practice, Circumstances of diagnosis, Screening


Mappa


© 2024  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 151 - N° 1

Articolo 103249- Marzo 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • French national protocol for the management of congenital ichthyosis
  • M. Severino-Freire, C. Granier Tournier, C. Chiaverini, A. Audouze, F. Morice-Picard, H. Texier, I. Dreyfus, A.-C. Bing-Lecointe, S. Mallet, C. Bodemer, J. Fischer, N. Jonca, J. Mazereeuw-Hautier, On behalf of the French Pediatric Dermatology Research Group
| Articolo seguente Articolo seguente
  • Correlation of serum level of squamous cell carcinoma antigen with severity of cutaneous psoriasis, assessed using the simplified psoriasis index
  • D. Henry, A. Alkhars, M. Samimi, D. Dufour, L. Machet

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.